Secondary Immunodeficiency (SID) Clinical Trials

5 clinical trials for Secondary Immunodeficiency (SID) across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma — RECRUITING · PHASE3
• Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency — RECRUITING
• Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project — RECRUITING
• Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment — OTHER · PHASE4
• Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study — COMPLETED

Refine this search